ReviewTherapeutic advances in hematology2021

Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.

Sotirios G Papageorgiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.